L
ADING

Articles

Will Theranos Turn the Lab Industry Upside Down?
Will Theranos Turn the Lab Industry Upside Down?
Theranos has received much praise along with a healthy dose of skepticism in recent months
Read more.
Nuclear Imaging Market Worth $2.2 Billion by 2020 for PET & SPECT Equipment Industry
Nuclear Imaging Market Worth $2.2 Billion by 2020 for PET & SPECT Equipment Industry
Complete report on the nuclear imaging market of PET and SPECT equipments spread across 318 pages.
Read more.
RBCC Aggressively Pursuing Personalized Medicine Opportunities in Canada
RBCC Aggressively Pursuing Personalized Medicine Opportunities in Canada
Rainbow Coral Corp. (RBCC) is taking full advantage of more research-friendly regulations.
Read more.
Now Health International and Best Doctors Insurance to Create a Leading Global International Private Medical Insurance Proposition
Actavis Announces Trial Results
Actavis Announces Trial Results
Company reveals outcome of Topline Phase 3 Clinical Trial for Single-Dose DALVANCE' (dalbavancin) in the Treatment of ABSSSI
Read more.
Resolving IP Disputes in the Pharma Industry
Resolving IP Disputes in the Pharma Industry
Papula Nevinpat was founded in 1975 and now has an 80-strong team in Finland.
Read more.
Driving Innovation  in Colonoscopy
Driving Innovation in Colonoscopy
In March 2014, medical device company, Invendo Medical, closed a US$28m financing round led by new investor Xeraya Capital
Read more.
Revolutionary New Concept of Heart Disease Threatens End of Global Statin Market
Revolutionary New Concept of Heart Disease Threatens End of Global Statin Market
Dr. Rath Research Institute: Revolutionary new concept of heart disease threatens end of global statin market
Read more.
Are Mobile Medical Apps Good for our Health?
Are Mobile Medical Apps Good for our Health?
The study, revealed today, looks into the use of mobile health apps.
Read more.
First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients
First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients
Merrimack Pharmaceuticals, Inc. has announced updated clinical data from a multi-arm Phase 1 study of MM-141, a bispecific antibody targeting
Read more.
5 Million Euros for Medical Innovation
5 Million Euros for Medical Innovation
All seven research projects are in line with the roadmap of the Dutch Top Sector.
Read more.